[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.130.145. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Citations 0
Correction
April 25, 2007

Incorrect Wording in: Trials Probe New Agents for Kidney Cancer

JAMA. 2007;297(16):1774. doi:10.1001/jama.297.16.1774

Incorrect Wording: In the Medical News & Perspectives story entitled “Trials Probe New Agents for Kidney Cancer” published in the July 12, 2006, issue of JAMA (2006;296:155-157), sunitinib was misidentified as a second-line treatment for advanced renal cell carcinoma. On page 155, column 2, the first full sentence should be “The results led to sunitinib's approval by the US Food and Drug Administration in January for advanced renal cell carcinoma.”

×